Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|January 25, 2020
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patientsRuxandra Calin, Stephanie Landowski, Marc-Antoine Valantin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 29, 2017
Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritisRuxandra Calin, Eric Caumes, Florence Reibel, et al.
Therapeutic Advances in Respiratory Disease|June 8, 2021
Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective studyThomas Maitre, Vichita Ok, Ruxandra Calin, et al.
AIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practiceMarc Wirden, Eve Todesco, Marc-Antoine Valantin, et al.
Spinal Cord Series and Cases|May 16, 2017
Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladderAurélien Dinh, Benjamin Davido, Ruxandra Calin, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2026
Lytic bacteriophages active in urine against multi-drug resistant clinically derived Klebsiella pneumoniae causing urinary tract infectionRuxandra Calin, Blanca Bernabeu Vilaplana, Judeline Gedeon, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2022
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trialAntoine Chéret, Rebecca Bauer, Vincent Meiffrédy, et al.
Pageof 3